Reversible Henoch–Schönlein purpura complicating adalimumab therapy

Danese, 2011, Causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-α therapy, Aliment Pharmacol Ther, 34, 1, 10.1111/j.1365-2036.2011.04679.x Rahman, 2010, Henoch–Schönlein purpura complicating adalimumab therapy for Crohn's disease, World J Gastrointest Pharmacol Ther, 1, 119, 10.4292/wjgpt.v1.i5.119 Lee, 2007, Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists, Br J Dermatol, 156, 486, 10.1111/j.1365-2133.2007.07682.x Pillebout, 2002, Henoch–Schönlein purpura in adults: outcome and prognostic factors, J Am Soc Nephrol, 13, 1271, 10.1097/01.ASN.0000013883.99976.22 Nobile, 2009, Herpes Zoster infection followed by Henoch–Schönlein purpura in a girl receiving infliximab for ulcerative colitis, J Clin Reumatol, 15, 101, 10.1097/RHU.0b013e31819bca9e Lee, 2006, Henoch–Schönlein purpura after etanercept therapy for psoriasis, J Clin Rheumatol, 12, 249, 10.1097/01.rhu.0000239901.34561.5e Duffy, 2006, Henoch–Schönlein purpura following etanercept treatment of rheumatoid arthritis, Clin Exp Rheumatol, 24, 106 Mohan, 2004, Leukocytoclastic vasculitis associated with tumor necrosis factor alpha blocking agents, J Rheumatol, 31, 1955 Roth, 1985, Schönlein–Henoch syndrome in adults, Q J Med, 55, 145 Cassinotti, 2008, Adalimumab for the treatment of Crohn's disease, Biologics, 2, 763 Boura, 2006, Eosinophilic cellulitis (Wells' syndrome) as a cutaneous reaction to the administration of adalimumab, Ann Rheum Dis, 65, 839, 10.1136/ard.2005.044685 Beuthien, 2004, Skin reaction to adalimumab, Arthritis Rheum, 50, 1690, 10.1002/art.20155 Salama, 2009, Stevens–Johnson syndrome complicating adalimumab therapy in Crohn's disease, World J Gastroenterol, 15, 4449, 10.3748/wjg.15.4449 McCarthy, 2001, Adult Henoch–Schönlein purpura with fatal complications, Arch Dermatol, 137, 19, 10.1001/archderm.137.1.19 Mills, 1990, The American College of Rheumatology 1990 criteria for the classification of Henoch–Schönlein purpura, Arthritis Rheum, 33, 1114, 10.1002/art.1780330809 Cassater, 2006, Henoch–Schönlein purpura and Crohn's disease in a family, J Nephrol, 19, 387 Saulsbury, 2000, Crohn's disease presenting with Henoch–Schonlein purpura, J Pediatr Gastroenterol Nutr, 31, 173, 10.1097/00005176-200008000-00015 Aringer, 2008, Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus, Expert Opin Drug Saf, 7, 411, 10.1517/14740338.7.4.411 Jarrett, 2003, Anti-tumor necrosis factor-α therapy-induced vasculitis: case series, J Rheumatol, 30, 2287